Evidence map›Paper›PMID 40438576›Full record

ArticleFrontiers in neurology2025

The determination of the boundaries and prediction the radicality of glioblastoma resection using MRI and CT perfusion.

Rustam Talybov, Tatiana Trofimova, Vadim Mochalov, Sergey Karasev, Vladislava Gorshkova, Tatiana Kleschevnikova, Irina Karasyova, Artem Batalov, Natalia Zakharova, Elena Gaijsina and 1 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rustam TalybovRegional Clinical Hospital, Tyumen, Russia.
Tatiana TrofimovaDepartment of Radiology, First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
Vadim MochalovRegional Clinical Hospital, Tyumen, Russia.
Sergey KarasevDepartment of Neurosurgery Federal Center of Neurosurgery, Tyumen, Russia.
Vladislava GorshkovaRegional Clinical Hospital, Tyumen, Russia.
Tatiana KleschevnikovaRegional Clinical Hospital, Tyumen, Russia.
Irina KarasyovaRegional Clinical Hospital, Tyumen, Russia.
Artem BatalovFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian, Moscow, Russia.
Natalia ZakharovaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian, Moscow, Russia.
Elena GaijsinaMultidisciplinary Clinical Medical Center "Medical City", Tyumen, Russia.
Igor ProninFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Preoperative identification of diffuse glioma boundaries remains an unsolved problem of modern neurooncology. The main problem is the heterogeneity of the tumor being manifested by simultaneous presence of both contrast-enhancing and non-contrasting but hyperperfused regions on imaging. Perfusion technologies are known to be a reliable tool in identifying areas with intact BBB and increased proliferative activity of vascular endothelium. Aim: The purpose of this study is to evaluate the impact of MRI and CT perfusion data in preoperative planning of surgical resection in order to achieve the maximum volume of cytoreduction and to prolong relapse-free period. Methods: The study included 74 patients with the morphologically and immunohistochemically verified diagnosis of "glioblastoma NOS." The patients were divided into 2 groups depending on the perfusion data and the extent of tumor resection. Group 1 of patients had a surgery with the preoperative use of perfusion techniques and the resection of the contrast-enhancing and hyperperfused portion of the tumor ( Results: The results of the study show that the surgery directed to the resection of contrast-positive and hyperperfused tumor portions has an advantage when compared with surgery aimed at removing only the contrast-enhancing part of the tumor. In group 1, the median relapse-free period was 15 months, while the relapse-free survival in 6 and 12 months was 92 and 55% which exceeded the results in the second group, in which the median was 9 months, and the relapse-free survival in 6 and 12 months was 66 and 9% ( Conclusion: Our study shows that the use of perfusion techniques in preoperative planning of the resection volume has a favorable potential and high diagnostic value. Perfusion tools may be contribute to the most objective assessment of all tumor components. The prolongation of the relapse-free period was achieved by taking into account the factor as the resection of both the contrast-enhanced component and the contrast-negative component with high vascular permeability detected by perfusion techniques.

Indexed as

cytoreduction volumeglioblastomaperfusionresidual tumor volumetumor boundaries

Identifiers

PMID40438576
PMCPMC12116550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.